A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Live Conference Call and Webcast TODAY at 4:30 p.m. ETENGLEWOOD, Colo., July 6, 2016 -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, will provide an overview of...
Live Conference Call and Webcast Scheduled for July 6, 2016, at 4:30 p.m. ETENGLEWOOD, Colo., June 30, 2016 -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology,...
Poster Presentation at 71st Annual Canadian Urological Society MeetingENGLEWOOD, Colo., June 28, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced...
Company Announces 1:12 Reverse Stock SplitENGLEWOOD, Colo., June 22, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced today a one-for-twelve (1:12)...
Establishes Initial European Distribution Network with Established Reproductive Health Companies for MiOXSYS™ SystemENGLEWOOD, Colo., June 13, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of...
ENGLEWOOD, Colo., June 6, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it has begun enrollment and patient dosing in their prostate...
ENGLEWOOD, Colo., May 31, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that its Chief Operating Officer, Jarrett Disbrow, and Managing...
Shareholders Authorize Board of Directors to Effect a Reverse Split of the Company's Common StockENGLEWOOD, Colo., May 25, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the...
ENGLEWOOD, Colo., May 24, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that its Chief Executive Officer, Josh Disbrow, will present at The...
ENGLEWOOD, Colo., May 18, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today provided an update on the strategic steps it has taken to expand and optimize...